Zymergen $125 Million Securities Class Action Settlement

Zymergen $125 Million Securities Class Action Settlement

By the Class Action Buddy Editorial Team · Last reviewed July 28, 2026

$6.21 per share
Max Payout
Oct 11, 2026
Filing Deadline
Yes
Proof Required?
Zymergen, a biotechnology company that went public in 2021, is at the center of a $125 million securities class action settlement. The lawsuit alleged that Zymergen and certain executives made misleading statements to investors about the company's business prospects and product pipeline before and after its IPO, leading investors to purchase shares at inflated prices. When the truth emerged, Zymergen's stock price dropped significantly, causing substantial financial losses for shareholders. If you purchased Zymergen stock during the relevant class period and suffered losses as a result, you may be entitled to a portion of the $125 million settlement fund. Securities class action settlements like this one exist to compensate everyday investors who were harmed by alleged corporate misrepresentations. Details about the exact claim deadline, payout amounts per share, and the official claim form are still being confirmed. Check back for updates, or download Class Action Buddy to get notified when the claim filing window opens.
🎯

Not sure if this settlement applies to you?

Take our 60-second eligibility quiz to find every settlement you qualify for — including this one.

Check Eligibility →

Who Is Eligible?

You may be eligible to file a claim if you:

  • You purchased or acquired Zymergen Inc. (ticker: ZY) common stock or other securities during the applicable class period
  • You suffered a financial loss as a result of the decline in Zymergen's stock price
  • You are a U.S. or international investor who held shares during the relevant period (securities settlements typically cover all shareholders, not just U.S.-based ones)
  • You did not opt out of the class action lawsuit prior to any court-set exclusion deadline
  • You have documentation of your Zymergen stock purchases and sales, such as brokerage statements or trade confirmations

How Much Can You Get?

The total settlement fund is $125 million, which is a significant recovery for investors. The exact amount each eligible claimant receives will depend on several factors, including how many shares you purchased, the prices at which you bought and sold, and how many total valid claims are submitted. Typically in securities settlements, payouts are calculated using a "plan of allocation" that assigns a recognized loss per share based on when shares were purchased and sold relative to alleged disclosure events. Specific per-share recovery amounts and the final payout formula have not yet been publicly confirmed. Once the court approves a plan of allocation, those details will be made available. The more valid claims that are filed, the more the fund is divided — so filing early and accurately is important.

How to File Your Claim

The administrator has not published a claim form for this settlement. The steps below are what filing will involve once one exists.

  • Gather your brokerage statements showing all purchases, sales, and holdings of Zymergen (ZY) stock during the class period
  • Note the dates and prices of each transaction, as this information will be required on the claim form
  • Visit the official settlement website (details pending) to access the claim form once it becomes available
  • Complete the claim form with your personal information and transaction history
  • Submit your claim before the court-approved deadline — missing the deadline means forfeiting your share of the settlement

File this one with the administrator

Class Action Buddy does not file this settlement for you — use the official claim process above. What the app does do is watch the open settlements list and tell you when a new one matches your profile.

Frequently Asked Questions

What is the deadline to file a claim for the Zymergen $125 Million Securities Class Action Settlement?

The current deadline to file a claim is Oct 11, 2026. Claims sent by mail must be postmarked by this date, so allow about a week for delivery if you are not filing online.

Do I need documentation for the Zymergen $125 Million Securities Class Action Settlement?

Yes — this settlement requires supporting documentation, and what counts is set out on the official claim form rather than being the same in every case: a consumer case may ask for receipts or order confirmations, while a financial or data-breach case usually turns on account records or the notice the administrator sent you. Note: some settlements still require a Claimant ID or PIN from a mailed notice; if this one does, it will be shown on the official claim form.

How do I file a claim for the Zymergen $125 Million Securities Class Action Settlement?

File directly with the settlement administrator, using the official claim form linked on this page. Class Action Buddy does not support this settlement in the app, so the administrator’s own claim process is the route. Check whether the form asks for an ID or PIN from the notice you were sent before you start.

Who qualifies for the Zymergen securities class action settlement?

Generally, investors who purchased Zymergen (ZY) stock during the defined class period and suffered losses when the stock price declined may qualify. You'll typically need brokerage records to prove your purchases and losses.

How much money will I get from the Zymergen settlement?

The total settlement fund is $125 million. Your individual payout will depend on how many shares you bought, at what price, and how many total claims are filed. Specific per-share amounts have not yet been announced.

What is the deadline to file a claim in the Zymergen settlement?

The official claim filing deadline has not yet been confirmed. Check back on this page for updates, or download Class Action Buddy to receive a notification when the deadline is set.

Do I need proof to file a Zymergen securities settlement claim?

Yes, securities settlement claims almost always require documentation. You'll need brokerage statements or trade confirmations showing your Zymergen stock purchases, sales, and the dates of those transactions.

What was the Zymergen lawsuit about?

The lawsuit alleged that Zymergen and its executives made false or misleading statements about the company's products and business outlook around the time of its 2021 IPO. When accurate information came to light, the stock price fell sharply, harming investors who had purchased shares at inflated prices.

Primary source: the official settlement administrator’s website named in the court-approved class notice. We track this settlement from public settlement-notice sources; a single official administrator claim URL was not on file, so confirm the details on the official settlement website before you file.

Class Action Buddy is an independent directory and is not affiliated with, endorsed by, or sponsored by the settlement administrator or the court. This page is general information, not legal advice. See how we verify settlements.

Ready to File Your Claim?

We're adding new settlements regularly. Download the app to get notified when this one is available.

Download Class Action Buddy →